Keros Therapeutics, Inc. (KROS): 8-K filed Aug 3, 2026

Form type

8-K

Filing date

Aug 3, 2026

Accession number

0001664710-26-000048

Filer

Keros Therapeutics, Inc. (CIK 1664710)